2 assets in Perceptual Disorders

Therapeutic assets addressing Perceptual Disorders, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Risperidone Perceptual Disorders	Spanish Foundation for Neurometrics Development	P1	NR ()
Sepofarsen Perceptual Disorders	Laboratoires Thea	P3	NR ()